Month: May 2022

Never-Before-Released Slam-Girl Superhero created in 2000 by Stan Lee and Marvel Animator Will Meugniot Uncovered by Former Marvel Comics Publisher Shirrel Rhoades will be showcased at MetaCon DUBAI, UAE, May 27, 2022 (GLOBE NEWSWIRE) — CYIOS Corp (OTC PINK: CYIO) – Dubai’s version of Comic-Con for the Metaverse, “MetaCon- Into the Metaverse” powered by GALA is being held this weekend at The Arena, Dubai World Trade Center. CYIOS Corp’s wholly owned subsidiary Immortals Group PTY (AU), in collaboration with SLH, LTD is pleased to announce the Slam-Girl CYBERspace NFT Collection will be previewed at Metacon along with the long-lost introductory webisode of Stan Lee’s Slam-Girl, the first super hero created to live in the Metaverse in a place called Stanleyville. Former Marvel Comics Publisher Shirrel Rhoades, who recently...

EDISON, N.J., May 27, 2022 (GLOBE NEWSWIRE) — In the press release issued earlier today by Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), we’ve been informed by the company that in both the headline and first paragraph the name ‘Recofilstat’ should be ‘Rencofilstat’. Completed corrected text follows.  Hepion Pharmaceuticals Highlights Upcoming Phase 2 Clinical Trials of Rencofilstat at 5th Global NASH Congress Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma (“HCC”), announces that its Chief Medical Officer, Todd Hobbs, MD, gave a clinical presentation entitled “Rencofilstat (CRV431): A liver-targeting...

New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that majority-owned subsidiary 3CL Pharma will present final data from the phase 2 clinical trial of Tollovir™ in the treatment of hospitalized (severe and critical) COVID-19 patients at the Personalized Medicine World Conference (PMWC) on June 30th, 2022 at 1:30pm Pacific Time.    “While the Company announced positive topline clinical results from this trial in late January earlier this year, it became clear that the final dataset with the biomarker data and other key clinical data results were going to be critical to allow the market to understand the full impact that Tollovir™ could have on the standard care in treatment...

On 27 May, 2022 Ministry of Energy of the Republic of Lithuania, announced a selection of candidates for members of the Supervisory Council of AB Klaipėdos nafta (hereinafter – the Company). The selection is announced for three members of the Supervisory Council of the Company: one for an independent member of the Supervisory Council in the field of finance management and audit, one for an independent member of the Supervisory Council in the field of strategic planning and management and one civil servant member of the Supervisory Council. The selection shall be performed according to the Description of Selection of Candidates for the Board of State or Municipal Enterprise and Candidates for Collegial Supervisory or Management Body Elected by the General Meeting of Shareholders of State or Municipal-Owned Company, approved by the Resolution...

HALIFAX, Nova Scotia, May 27, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe and any market accepting the CE mark. MedMira has received the CE mark for three products in 2022 and has four additional applications currently pending with the regulatory body. As of today, the Company has been informed that all applications have been accepted and will be forwarded to the Competent Authority for final CE marking. The Company anticipates the respective decisions and CE marks within the coming weeks. With these steps, the Company has completed its application prior to the change from the In Vitro Diagnostic Medical Devices [98/79/EC: IVD] to the new In Vitro Diagnostic Medical Devices Regulation [EU 2017/746: IVDR] which was set for the 26th of May 2022. EU 2017/746:...

WINSTON-SALEM, N.C., May 27, 2022 (GLOBE NEWSWIRE) — Millions across the country have plans this Memorial Day weekend to honor America’s military heroes by gathering and enjoying a meal prepared on their propane grill. Blue Rhino, the propane tank exchange brand of Ferrellgas Partners, L.P. (OTC: FGPR), wants to help grillers do so safely. “Memorial Day is so important to us at Blue Rhino as a day to remember our nation’s fallen. It’s also long been considered the official start to summer,” VP of Blue Rhino Operations Geoffrey Jaynes said. “As America’s leading propane tank-exchange brand, Blue Rhino is proud to be at the heart of these special summer cookouts with friends and family.” According to Blue Rhino, here are some helpful grilling tips to keep in mind this Memorial Day weekend and every time you fire up the grill.Always...

SHENZHEN, China, May 27, 2022 (GLOBE NEWSWIRE) — Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a leading property technology company in China, today announced that it plans to change the ratio of the American depositary shares (“ADSs”) to its Class A ordinary shares from one (1) ADS representing twenty-five (25) Class A ordinary share to one (1) ADS representing three hundred seventy-five (375) Class A ordinary shares. For the Company’s ADS holders, the change in the ADS ratio will have the same effect as a one-for-fifteen reverse ADS split. There will be no change to the Company’s Class A ordinary shares. The effect of the ratio change on the ADS trading price on Nasdaq is expected to take place at the open of trading on June 7, 2022 (U.S. Eastern Time). ADS holders of record on the effective date will not...